Bavarian Nordic A/S (CPH:BAVA)
Denmark · Delayed Price · Currency is DKK 245.40
-2.40 (-0.97%)
Oct 30, 2026, 4:59 PM CET
Bavarian Nordic Market Cap
Bavarian Nordic has a market cap or net worth of 18.58 billion as of October 30, 2026. It is the 5,295th most valuable company in the world and the 28th biggest in Denmark. Its market cap has decreased by 1.27% in one year.
Market Cap
18.58B
Enterprise Value
16.35B
Revenue
6.34B
Global Rank
Country Rank
#28 Denmark
PE Ratio
12.64
ChartMarket Cap Chart
Since November 5, 1998, Bavarian Nordic's market cap has increased from 42.71M to 18.58B, an increase of 43,396.70%. That is a compound annual growth rate of 24.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 18.58B | 24.37% |
| Dec 30, 2025 | 14.94B | 0.41% |
| Dec 30, 2024 | 14.88B | 7.57% |
| Dec 29, 2023 | 13.83B | -8.19% |
| Dec 30, 2022 | 15.06B | -20.32% |
| Dec 30, 2021 | 18.90B | 73.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.18T |
| Genmab | 233.76B |
| Coloplast | 108.60B |
| Demant | 77.06B |
| ALK-Abelló | 55.03B |
| H. Lundbeck | 53.06B |
| Ambu A/S | 21.20B |
| Zealand Pharma | 15.95B |